Literature DB >> 32033821

Imaging Features of Triple Negative Breast Cancer and the Effect of BRCA Mutations.

Niloofar Karbasian1, Sahand Sohrabi2, Toma S Omofoye3, Huong Le-Petross3, Banu K Arun4, Constance T Albarracin5, Kenneth R Hess6, Angelica M Gutierrez-Barrera4, Gary J Whitman7.   

Abstract

OBJECTIVE: The purpose of this study is to review the mammographic and the ultrasound features of triple negative breast cancer (TNBC) patients and to investigate the potential effect of BRCA mutations on the imaging features of these patients.
METHODS: One hundred and seven patients with TNBC were enrolled in a retrospective study following IRB approval and approval of waiver of informed consent. BRCA mutations were assessed using genetic testing. Imaging features on mammography and ultrasound (US) as well as pathology and clinical information were retrospectively reviewed and characterized according to the BI-RADS lexicon (fifth edition). The relationships between BRCA mutations and the imaging findings were examined.
RESULTS: TNBC commonly presented as an irregular mass with obscured margins on mammography and as an irregular hypoechoic mass with microlobulated or angular margins on US. Approximately two thirds of TNBC cases had a parallel orientation and approximately one third had posterior enhancement, features often associated with benign masses. There was no statistically significant difference in the mammographic and the US features of BRCA positive and BRCA negative triple negative tumors.
CONCLUSION: TNBC may have a parallel orientation and posterior enhancement, which are features often seen with benign masses. BRCA mutations do not affect the imaging features of triple negative breast tumors.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32033821      PMCID: PMC7340565          DOI: 10.1067/j.cpradiol.2020.01.011

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  20 in total

1.  Triple-negative breast cancer: clinical features and patterns of recurrence.

Authors:  Rebecca Dent; Maureen Trudeau; Kathleen I Pritchard; Wedad M Hanna; Harriet K Kahn; Carol A Sawka; Lavina A Lickley; Ellen Rawlinson; Ping Sun; Steven A Narod
Journal:  Clin Cancer Res       Date:  2007-08-01       Impact factor: 12.531

2.  BRCA1-associated breast carcinomas frequently present with benign sonographic features.

Authors:  Kerstin Rhiem; Uta Flucke; Rita K Schmutzler
Journal:  AJR Am J Roentgenol       Date:  2006-05       Impact factor: 3.959

3.  Impact of MRI surveillance and breast cancer detection in young women with BRCA mutations.

Authors:  E Warner
Journal:  Ann Oncol       Date:  2011-01       Impact factor: 32.976

4.  Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.

Authors:  Florentia Fostira; Marianthi Tsitlaidou; Christos Papadimitriou; Maroulio Pertesi; Eleni Timotheadou; Alexandra V Stavropoulou; Stavros Glentis; Evangelos Bournakis; Mattheos Bobos; Dimitrios Pectasides; Pavlos Papakostas; George Pentheroudakis; Helen Gogas; Pantelis Skarlos; Epaminontas Samantas; Dimitrios Bafaloukos; Paris A Kosmidis; Angelos Koutras; Drakoulis Yannoukakos; Irene Konstantopoulou; George Fountzilas
Journal:  Breast Cancer Res Treat       Date:  2012-03-21       Impact factor: 4.872

5.  Triple receptor-negative breast cancer: imaging and clinical characteristics.

Authors:  Kristin M Krizmanich-Conniff; Chintana Paramagul; Stephanie K Patterson; Mark A Helvie; Marilyn A Roubidoux; Jamie D Myles; Kiting Jiang; Michael Sabel
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

6.  Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.

Authors:  Huong T Le-Petross; Gary J Whitman; Deanne P Atchley; Ying Yuan; Angelica Gutierrez-Barrera; Gabriel N Hortobagyi; Jennifer K Litton; Banu K Arun
Journal:  Cancer       Date:  2011-03-01       Impact factor: 6.860

Review 7.  BRCA1/2 mutations and triple negative breast cancers.

Authors:  Beth N Peshkin; Michelle L Alabek; Claudine Isaacs
Journal:  Breast Dis       Date:  2010

8.  Mammographic, US, and MR imaging phenotypes of familial breast cancer.

Authors:  Simone Schrading; Christiane K Kuhl
Journal:  Radiology       Date:  2008-01       Impact factor: 11.105

9.  Meta-analysis of BRCA1 and BRCA2 penetrance.

Authors:  Sining Chen; Giovanni Parmigiani
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

10.  The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.

Authors:  S R Young; Robert T Pilarski; Talia Donenberg; Charles Shapiro; Lyn S Hammond; Judith Miller; Karen A Brooks; Stephanie Cohen; Beverly Tenenholz; Damini Desai; Inuk Zandvakili; Robert Royer; Song Li; Steven A Narod
Journal:  BMC Cancer       Date:  2009-03-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.